Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00866840Phase 2Completed
A Phase 2 trial of riluzole in melanoma, sponsored by Rutgers University. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00866840.